Search

everythinglearnresearchcommunity

for

Search:↓

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

Some ovarian tumors can cause masculinization, and it's important to check for various causes when this symptom is present.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

Hormones affect skin aging, and treatments targeting hormonal balance may improve skin health.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

A reliable system was developed to distinguish hair growth stages, aiding in identifying hair growth promoters or inhibitors.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

c-Myc activation in mouse skin increases sebaceous gland growth and affects hair follicle development.

Myc activation reduces skin stem cells by affecting cell adhesion.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Retinoic acid-binding proteins in skin are regulated by β-catenin and Notch signalling.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

17β-estradiol can reduce inflammation in the skin.

Estrogen can temporarily slow down hair growth but this can be reversed.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.